Literature DB >> 17016511

Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

C H R Wallace1, I Baczkó, L Jones, M Fercho, P E Light.   

Abstract

BACKGROUND AND
PURPOSE: The cardiovascular benefits of red wine consumption are often attributed to the antioxidant effects of its polyphenolic constituents, including quercetin, catechin and resveratrol. Inhibition of cardiac voltage-gated sodium channels (VGSCs) is antiarrhythmic and cardioprotective. As polyphenols may also modulate ion channels, and possess structural similarities to several antiarrhythmic VGSC inhibitors, we hypothesised that VGSC inhibition may contribute to cardioprotection by these polyphenols. EXPERIMENTAL APPROACH: The whole-cell voltage-clamp technique was used to record peak and late VGSC currents (INa) from recombinant human heart NaV1.5 channels expressed in tsA201 cells. Right ventricular myocytes from rat heart were isolated and single myocytes were field-stimulated. Either calcium transients or contractility were measured using the calcium-sensitive dye Calcium-Green 1AM or video edge detection, respectively. KEY
RESULTS: The red grape polyphenols quercetin, catechin and resveratrol blocked peak INa with IC50s of 19.4 microM, 76.8 microM and 77.3 microM, respectively. In contrast to lidocaine, resveratrol did not exhibit any frequency-dependence of peak INa block. Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin. Resveratrol and quercetin also blocked late INa induced by the toxin, ATX II, with IC50s of 26.1 microM and 24.9 microM, respectively. In field-stimulated myocytes, ATXII-induced increases in diastolic calcium were prevented and reversed by resveratrol. ATXII-induced contractile dysfunction was delayed and reduced by resveratrol. CONCLUSIONS AND IMPLICATIONS: Our results indicate that several red grape polyphenols inhibit cardiac VGSCs and that this effect may contribute to the documented cardioprotective efficacy of red grape products.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016511      PMCID: PMC2014645          DOI: 10.1038/sj.bjp.0706897

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunits expressed in tsA201 cells.

Authors:  M Chahine; E Plante; R G Kallen
Journal:  J Membr Biol       Date:  1996-07       Impact factor: 1.843

Review 2.  The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease.

Authors:  M Karmazyn; X T Gan; R A Humphreys; H Yoshida; K Kusumoto
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

3.  Hypoxia increases persistent sodium current in rat ventricular myocytes.

Authors:  Y K Ju; D A Saint; P W Gage
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

4.  Inhibition of human LDL oxidation by resveratrol.

Authors:  E N Frankel; A L Waterhouse; J E Kinsella
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

5.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

6.  The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.

Authors:  C R Pace-Asciak; S Hahn; E P Diamandis; G Soleas; D M Goldberg
Journal:  Clin Chim Acta       Date:  1995-03-31       Impact factor: 3.786

7.  Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes.

Authors:  J Wu; P B Corr
Journal:  Am J Physiol       Date:  1994-03

8.  Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.

Authors:  G W Zamponi; R J French
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

9.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.

Authors:  Q Wang; J Shen; I Splawski; D Atkinson; Z Li; J L Robinson; A J Moss; J A Towbin; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

10.  Antiplatelet activity of synthetic and natural resveratrol in red wine.

Authors:  A A Bertelli; L Giovannini; D Giannessi; M Migliori; W Bernini; M Fregoni; A Bertelli
Journal:  Int J Tissue React       Date:  1995
View more
  20 in total

1.  Nav channel mechanosensitivity: activation and inactivation accelerate reversibly with stretch.

Authors:  Catherine E Morris; Peter F Juranka
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

2.  Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats.

Authors:  Yun Zhang; Song Zhang; Zonghong Liu; Xinbo Zhao; Yue Yuan; Li Sheng; Yue Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-22       Impact factor: 3.000

3.  The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Loipa Galán; Ariel Talavera; Julio L Alvarez; Karel Talavera
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

4.  Metabolic constituents of grapevine and grape-derived products.

Authors:  Kashif Ali; Federica Maltese; Young Hae Choi; Robert Verpoorte
Journal:  Phytochem Rev       Date:  2009-11-08       Impact factor: 5.374

5.  Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.

Authors:  Istvan Baczko; David Liknes; Wei Yang; Kevin C Hamming; Gavin Searle; Kristian Jaeger; Zoltan Husti; Viktor Juhasz; Gergely Klausz; Robert Pap; Laszlo Saghy; Andras Varro; Vernon Dolinsky; Shaohua Wang; Vivek Rauniyar; Dennis Hall; Jason Rb Dyck; Peter E Light
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin.

Authors:  Koenraad Philippaert; Subha Kalyaanamoorthy; Mohammad Fatehi; Wentong Long; Shubham Soni; Nikole J Byrne; Amy Barr; Jyoti Singh; Jordan Wong; Taylor Palechuk; Chloe Schneider; Ahmed M Darwesh; Zaid H Maayah; John M Seubert; Khaled Barakat; Jason R B Dyck; Peter E Light
Journal:  Circulation       Date:  2021-04-09       Impact factor: 29.690

7.  Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes.

Authors:  Chunping Qian; Jihua Ma; Peihua Zhang; Antao Luo; Chao Wang; Zhiqiang Ren; Linghao Kong; Shuo Zhang; Xiaojing Wang; Ying Wu
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 8.  Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.

Authors:  Khushwant S Bhullar; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

9.  Mechanisms of the antinociceptive action of (-) epicatechin obtained from the hydroalcoholic fraction of Combretum leprosum Mart & Eic in rodents.

Authors:  Luciano da Silva Lopes; Rosemarie Brandin Marques; Heliana Barros Fernandes; Sergio da Silva Pereira; Mariane C C Ayres; Mariana Helena Chaves; Fernanda R C Almeida
Journal:  J Biomed Sci       Date:  2012-07-25       Impact factor: 8.410

Review 10.  Ion channel pharmacology.

Authors:  Diana Conte Camerino; Domenico Tricarico; Jean-François Desaphy
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.